Opening Date	July 27, 2021
Closing Date	July 29, 2021
Face Value	Rs. 2 per equity share
IPO Price	Rs. 695 to Rs. 72 per equity share
Minimum Order Quantity	20 equity shares
Issue Size	Rs. 1,513.60 crores

One of India’s leading pharmaceutical companies, Glenmark Life Sciences, has finally filed the Red Herring Prospectus with the SEBI in connection with its latest IPO. The SEBI has also recently approved the RHP of Glenmark Life Sciences and has given a green light. And so, here are some key Glenmark Life Sciences IPO details that we know of as of today.  

• About the company 

Incorporated in 2011, Glenmark Life Sciences Limited quickly rose through the pharmaceutical industry ranks and is now currently one of the country’s leading manufacturers and suppliers of drugs. 

The company’s primary business involves the manufacture of Active Pharmaceutical Ingredients (APIs) spanning across various therapeutic segments such as pain management, oncology, anti-infectives, central nervous system disorders, diabetes, cardiovascular disease, and gastrointestinal health.  

The product portfolio of Glenmark Life Sciences is quite extensive and comprises around 120 APIs. And the company also supplies its drugs to over 540 pharmaceutical companies throughout the world, including Latin America, India, North America, Europe, and Japan, among others.  

• Glenmark Life Sciences IPO details

Now that you’re aware of the company, let’s take a look at some of the key details of Glenmark Life Sciences IPO such as the Glenmark Life Sciences IPO date and the Glenmark Life Sciences IPO share price. 

• Glenmark Life Sciences IPO date 

The opening and closing dates of the Upcoming IPO 2023 of the company have been notified as July 27, 2021 and July 29, 2021 respectively. 

• Glenmark Life Sciences IPO issue size

The latest IPO of Glenmark Life Sciences Limited consists of both a fresh issue of shares and an offer for sale (OFS). The fresh issue of shares component is likely to net around Rs. 1,060 crores for the company. On the other hand, the promoters of the company are planning to offer around 6,300,000 equity shares for sale through the OFS component aggregating up to Rs. 453.60 crores. 

• Glenmark Life Sciences IPO share price

Along with the filing of the Red Herring Prospectus with the SEBI, the company has also revealed the IPO price band . The IPO has been priced from Rs. 695 per equity share to Rs. 720 per equity share. As you can see, the IPO pricing carries a hefty premium.  

• Glenmark Life Sciences IPO listing

The shares of the company are likely to be listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). 

• Glenmark Life Sciences IPO objectives

Glenmark Life Sciences has notified that it would use the net proceeds from its IPO for paying off outstanding purchase considerations and for funding capital expenditures.

Conclusion

Investing in an IPO such as the one from Glenmark Life Sciences requires you to have a demat account. If you don’t have one already, Motilal Oswal can help you out. Get in touch with us right now and open a demat account with us for free.

Before commencing online trading, always remember to open a demat account and trading account with a trusted and reliable financial partner.

If you already have an existing account, you can  start your online trading and invest in the upcoming IPO's.

With a plethora of companies coming forward with their own IPOs in quick succession, you can keep a track of all the upcoming IPOs by regularly following our IPO calendar.
 

Related IPO Articles: GoAir IPO | Krishna institute of medical science (KIMS) IPO | Seaborne Logistics IPO | Seven Islands Shipping IPO | Arohan Financial Services IPO | Exxaro Tiles IPO | India Pesticides IPO | Paras Defence and space technologies IPO | Utkarsh small finance bank IPO | Dodla Dairy IPO | Montecarlo Limited IPO | Sona BLW Precision Forgings Ltd IPO